237 related articles for article (PubMed ID: 1426029)
21. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
22. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
23. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
Ogletree ML; Allen GT
J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
[TBL] [Abstract][Full Text] [Related]
24. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
25. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes.
Theis JG; Dellweg H; Perzborn E; Gross R
Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312
[TBL] [Abstract][Full Text] [Related]
26. Antagonism of thromboxane actions in the isolated perfused rat heart.
Stahl GL; Darius H; Lefer AM
Life Sci; 1986 Jun; 38(22):2037-41. PubMed ID: 2940431
[TBL] [Abstract][Full Text] [Related]
27. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
[No Abstract] [Full Text] [Related]
28. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145.
Hanasaki K; Nagasaki T; Arita H
Biochem Pharmacol; 1989 Jun; 38(12):2007-17. PubMed ID: 2525906
[TBL] [Abstract][Full Text] [Related]
29. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells.
Hunt JA; Merritt JE; MacDermot J; Keen M
Biochem Pharmacol; 1992 Apr; 43(8):1747-52. PubMed ID: 1315543
[TBL] [Abstract][Full Text] [Related]
31. Constriction of cat coronary arteries by synthetic thromboxane A2 and its antagonism.
Smith JB; Yanagisawa A; Zipkin R; Lefer AM
Prostaglandins; 1987 Jun; 33(6):777-82. PubMed ID: 3671730
[TBL] [Abstract][Full Text] [Related]
32. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
33. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
[TBL] [Abstract][Full Text] [Related]
34. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
35. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
Dorn GW; Becker MW; Davis MG
J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
[TBL] [Abstract][Full Text] [Related]
36. Glomerular thromboxane A2/prostaglandin H2 receptors: characterization and effect of adriamycin-induced nephrotic syndrome.
Mayeux PR; Shah SV
Biochim Biophys Acta; 1993 Apr; 1181(2):148-54. PubMed ID: 8481403
[TBL] [Abstract][Full Text] [Related]
37. Thromboxane A2/prostaglandin H2 receptor antagonists.
Le Breton GC; Lim CT; Vaidya CM; Venton DL
Methods Enzymol; 1990; 187():406-14. PubMed ID: 2146463
[No Abstract] [Full Text] [Related]
38. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells.
Fukunaga M; Makita N; Roberts LJ; Morrow JD; Takahashi K; Badr KF
Am J Physiol; 1993 Jun; 264(6 Pt 1):C1619-24. PubMed ID: 8333509
[TBL] [Abstract][Full Text] [Related]
39. Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors.
Bayon Y; Croset M; Daveloose D; Guerbette F; Chirouze V; Viret J; Kader JC; Lagarde M
J Lipid Res; 1995 Jan; 36(1):47-56. PubMed ID: 7706947
[TBL] [Abstract][Full Text] [Related]
40. Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.
Hedberg A; Hall SE; Ogletree ML; Harris DN; Liu EC
J Pharmacol Exp Ther; 1988 Jun; 245(3):786-92. PubMed ID: 2968449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
